SCHEMBL7233451

SCHEMBL7233451

CCOC(=O)C(C)(NC(=O)OC(C)(C)C)c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 2/20 0.45
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAOA P21397 1/20 0.42
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 1/20 0.40
RECQL P46063 1/20 0.40
PPIB P23284 1/20 0.39
PPIA P62937 1/20 0.39
PPID Q08752 1/20 0.39
PPIG Q13427 1/20 0.39
MMP8 P22894 1/20 0.37
PRKCZ Q05513 1/20 0.36
EPHX2 P34913 1/20 0.35
CNR2 P34972 1/20 0.35
PKM P14618 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925457 0.86 PTPRB (0.42) PTPRBCYP1A2CYP3A4ALDH1A1RECQL
SCHEMBL2490507 0.86 ABCB11 (0.49) PTPRBCYP1A2CYP3A4ALDH1A1RECQL
SCHEMBL18053930 0.86 PTPRB (0.38) PTPRBMAPK1ALDH1A1EPHX2CNR2
SCHEMBL18053708 0.86 PTPRB (0.38) PTPRBMAPK1ALDH1A1EPHX2CNR2
SCHEMBL18037868 0.86 PTPRB (0.38) PTPRBMAPK1ALDH1A1EPHX2CNR2
SCHEMBL1509032 0.85 KMT2A (0.44) PTPRBLMNACYP1A2CYP3A4MAPK1
SCHEMBL1111262 0.81 PTPRB (0.39) PTPRBALDH1A1RECQLMMP8EPHX2
SCHEMBL18054013 0.81 EPHX2 (0.38) PTPRBLMNACYP1A2CYP3A4MAOA
SCHEMBL1508958 0.80 GAA (0.42) PTPRBLMNACYP1A2CYP3A4ALDH1A1
SCHEMBL10282363 0.76 EPHX2 (0.39) LMNAMAPK1ALDH1A1RECQLEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed
EP-1100779-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2001-05-23 EP disclosed
WO-1999062882-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed